Browsing by Author Hellard, Margaret

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 20
Issue DateTitleAuthor(s)Citation
2017Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE studyWeltman, Martin; Amin, Janaki; Backmund, Markus; Bruggmann, Philip; Conway, Brian; Cunningham, Evan B.; Dalgard, Olav; et al, Various; Foster, Graham R; Hajarizadeh, Behzad; Hellard, Margaret; Nepean Clinical School: MedicineAdherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study, BMC Infectious Diseases, vol.17, 1, 2017,pp 1-12
2009Antenatal screening practice for infectious diseases by general practitioners in AustraliaJones, Cheryl; Garland, Suzanne M.; Giles, Michelle; Hellard, Margaret; Lewin, Sharon R.; Pedrana, Alisa; Children's Hospital Westmead: Paediatrics & Child HealthAntenatal screening practice for infectious diseases by general practitioners in Australia, Australian and New Zealand Journal of Obstetrics and Gynaecology, vol.49, 1,pp 39-44
2010Antibody persistence six years after two doses of combined hepatitis A and B vaccineBurgess, Margaret; McIntyre, Peter; Bock, Hans Ludwig; Hellard, Margaret; Lefevre, Inge; Ruff, Tilman A.; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child HealthAntibody persistence six years after two doses of combined hepatitis A and B vaccine, Vaccine, vol.28, 10, 2010,pp 2222-2226
2014Assessing the feasibility of hepatitis C virus vaccine trials: Results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness studyWhite, Bethany; Dore, Gregory; Hellard, Margaret; Madden, Annie; Maher, Lisa; Page, Kimberly; Prins, Maria; Wand, Handan; Central Clinical School: Addiction MedicineAssessing the feasibility of hepatitis C virus vaccine trials: Results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study, Vaccine, vol.32, 42, 2014,pp 5460-5467
2009Characteristics and treatment outcomes among HIV-infected individuals in the Australian trial in acute hepatitis CHaber, Paul; McCaughan, Geoffrey William; Baker, D; Dore, Gregory J.; Hellard, Margaret; Kaldor, J; Lloyd, Andrew; Marks, P; Matthews, G; Rawlinson, William; Sasadeusz, J; White, Peter A; Yeung, B; Central Clinical School: Addiction Medicine; Central Clinical School: Centenary InstituteCharacteristics and treatment outcomes among HIV-infected individuals in the Australian trial in acute hepatitis C, Clinical Infectious Diseases, vol.48, 5, 2009,pp 650-658
2017A cross-sectional study of HIV and STIs among male sex workers attending Australian sexual health clinicsLewis, David; Ali, Hammad; Callander, D; Chow, Eric; Donovan, Basil; Guy, Rebecca; Hellard, Margaret; McNulty, Anna; Minichiello, V; Prestage, G; Read, Phillip; Western Clinical School: Medicine (Westmead)A cross-sectional study of HIV and STIs among male sex workers attending Australian sexual health clinics, Sexually Transmitted Infections, vol.93, 4, 2017,pp 299-302
2014Detection of HCV-Specific IFN-gamma Responses in HCV Antibody and HCV RNA Negative Injecting Drug UsersGeorge, Jacob; Suppiah, Vijayaprakash; Aitken, Campbell; Bharadwaj, Mandvi; Bowden, Scott; Drummer, Heidi; Ffrench, Rosemary; Flynn, Jacqueline K.; Hellard, Margaret; Higgs, Peter; Moneer, Sarah; Sacks-Davis, Rachel; Tracy, Lilly; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteDetection of HCV-Specific IFN-gamma Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users, Hepatitis Monthly, vol.14, 1, 2014,pp 1-14
2012Effect of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infectionDay, Carolyn; Haber, Paul; Alavi, Maryam; Dore, Gregory; Grebely, Jason; Hellard, Margaret; Kaldor, John; Lloyd, Andrew; Matthews, Gail V; Petoumenos, Kathy; van Beek, I; Yeung, Barbara; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineEffect of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infection, Journal of Gastroenterology and Hepatology, vol.27, 5, 2012,pp 957-965
2010Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection.Haber, Paul; McCaughan, Geoffrey; Dore, Gregory; et al, various; Grebely, Jason; Hellard, Margaret; Marks, Phillipa; Matthews, G; Petoumenos, Kathy; van Beek, I; White, Peter A; Yeung, B; Central Clinical School: Addiction Medicine; Central Clinical School: Centenary InstituteEffective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection., Gastroenterology, vol.138, 1,pp 123-135.e1-2
2010Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC StudyHaber, Paul; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew; Marks, P; Matthews, G; Petoumenos, Kathy; Central Clinical School: Addiction MedicineFactors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study, Drug and Alcohol Dependence, vol.107, 40239,pp 244-249
2014High chlamydia positivity rates in Indigenous people attending Australian sexual health servicesTempleton, David; Chen, Marcus Y; Dickson, Bridget; Donovan, Basil; Fairley, Christopher; Grulich, Andrew E; Guy, Rebecca; Hammad, Ali; Hellard, Margaret; Kaldor, John M.; Marshall, Lewis; O'Connor, Catherine; Ward, James; School of Public Health: Public HealthHigh chlamydia positivity rates in Indigenous people attending Australian sexual health services, Medical Journal of Australia, vol.200, 10, 2014,pp 595-598
2013High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: A prospective cohort studyGeorge, Jacob; Suppiah, Vijayaprakash; Atiken, Campbell; Bharadwaj, Mandvi; Bowden, S; Drummer, Heidi; Grebely, Jason; Hellard, Margaret; Higgs, Peter; Nivarthi, Usha; Pedrana, Alisa; Sacks-Davis, Rachel; Spelman, T; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteHigh rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: A prospective cohort study, PLoS One, vol.8, 11, 2013,pp 1-12
2011IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study.Ahlenstiel, Golo; Booth, David; George, Jacob; O'Connor, Kate; Stewart, Graeme; Suppiah, Vijayaprakash; Weltman, Martin; Abate, Maria; Armstrong, Nicola; Bassendine, Maragaret; Berg, Thomas; Dore, Gregory J.; et al, various; Gaudieri, Silvana; Hellard, Margaret; Irving, William; Powell, Elizabeth E.; Spengler, Ulrich; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Nepean Clinical School: MedicineIL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study., PLoS Medicine, vol.8, 9, 2011,pp e1001092-1-e1001092-8
2016The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New ZealandStrasser, Simone; Angus, Peter W.; Balderson, Glenda; Gane, Edward; Gow, Paul; Hellard, Margaret; Howell, Jessica; Jeffrey, Gary P.; Stuart, Katherine; Wigg, Alan; Central Clinical School: MedicineThe increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New Zealand, Journal of Gastroenterology and Hepatology, vol.31, 2, 2016,pp 434-441
2013Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infectionGeorge, Jacob; Applegate, Tanya; Bruneau, Julie; Cherepanov, Vera; Dore, Gregory; Feld, Jordan; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew; Matthews, Gail; Petoumenos, Kathy; Shaw, Ineke; Sherker, Alana; Shoukry, Naglaa H.; Teutsch, Suzy; Yeung, Barbara; Zang, Geng; Western Clinical School: Westmead Millennium InstitutePlasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection, Hepatology, vol.57, 6, 2013,pp 2124-2134
2010Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus InfectionBooth, David; George, Jacob; Suppiah, Vijayaprakash; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew R.; Marks, Phillipa; Matthews, Gail V; Petoumenos, Kathy; Rawlinson, William; Yeung, Barbara; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstitutePotential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection, Hepatology, vol.52, 4, 2010,pp 1216-1224
2016Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studiesHaber, Paul; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Iser, David M.; Lloyd, Andrew; Maire, Laurence; Martinello, Marianne; Matthews, Gail; Petoumenos, Kathy; Sasadeusz, J; Shaw, David R; Thompson, Alexander; Yeung, Barbara; Central Clinical School: Addiction MedicineShort duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies, Antiviral Therapy, vol.21, 5, 2016,pp 425-434
2016Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studiesHaber, Paul; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Iser, David M.; Lloyd, Andrew; Maire, Laurence; Martinello, Marianne; Matthews, Gail; Petoumenos, Kathy; Sasadeusz, J; Shaw, David R; Thompson, Alexander; Yeung, Barbara; Central Clinical School: Addiction MedicineShort duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies, Antiviral Therapy, vol.21, 5, 2016,pp 425-434
2008Variable uptake of recommended interventions to reduce mother-to-child transmission of HIV in Australia, 1982-2005Elliott, Elizabeth; Giles, Michelle; Hellard, Margaret; Kaldor, John; Lewin, Sharon; McDonald, Ann; Ziegler, John; Children's Hospital Westmead: Paediatrics & Child HealthVariable uptake of recommended interventions to reduce mother-to-child transmission of HIV in Australia, 1982-2005, Medical Journal of Australia, vol.189, 3, 2008,pp 151-154
2012Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infectionGeorge, Jacob; Applegate, Tanya; Dore, Gregory; Feld, Jordan; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew; Matthews, Gail V; Petoumenos, Kathy; Rawlinson, William; Yeung, Barbara; Western Clinical School: Westmead Millennium InstituteVirological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection, AIDS, vol.26, 13, 2012,pp 1653-1661